Inactive Instrument

World Medtronic, Inc. Stock Monde

Equities

US5850551061

Medical Equipment, Supplies & Distribution

End-of-day quote Monde
- EUR - Intraday chart for Medtronic, Inc.

Financials

Sales 2025 * 33.42B 31.28B 45.77B Sales 2026 * 35.03B 32.79B 47.97B Capitalization 103B 96.51B 141B
Net income 2025 * 5.02B 4.7B 6.87B Net income 2026 * 5.72B 5.36B 7.84B EV / Sales 2025 * 3.7 x
Net Debt 2025 * 20.49B 19.18B 28.06B Net Debt 2026 * 19.34B 18.1B 26.49B EV / Sales 2026 * 3.5 x
P/E ratio 2025 *
21.9 x
P/E ratio 2026 *
19 x
Employees -
Yield 2025 *
3.41%
Yield 2026 *
3.53%
Free-Float 99.77%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 54 15-01-25
Director of Finance/CFO 58 16-05-31
Chief Operating Officer 63 21-03-31
Members of the board TitleAgeSince
Director/Board Member 62 12-12-31
Director/Board Member 70 06-12-31
Director/Board Member 68 14-12-31
More insiders
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company